On the sea floor, over 10,000 feet below us, lies a world very different from ours. The sheer depth of the sea floor ensures that few can unravel the mysteries it contains, as even catching a glimpse is no simple task! Nevertheless, man's desire to discover and explore our world is insatiable, and we have developed various ways to study and understand the world beneath us.
A quick peek into the depths of the sea reveals various tidbits of history here and there, as shown by the recent photographs released by the Irish National Seabed Survey, where scientists have been scanning under the waves since 1996. Most of the photographs are from deep water areas where the sonar-equipped ships can easily sail. The pictures show a 20 kilometer trench which is up to 30 meters deep, a possible indication of a geological fault.
There were also broad troughs carved into the sea floor during or soon after the last ice age, over 10,000 years ago. The sea floor sonar images also showed the large number of sunken German U-boats.
Even farther down, in the depths of the Pacific's Marianna Trench, over 36,000 feet below sea level, lives a thriving ecosystem never seen before by the likes of man. Scientists have long thought that in the depths of the ocean, there can be no life due to the extreme conditions. The immense pressure, the lack of oxygen, the complete darkness and low temperatures of the sea bed have always been thought to lead invariably to a sea floor ecosystem dominated by bacteria.
However, recent studies have demonstrated that even as bacteria dominate the upper ten centimeters of the sea floor, simple organisms known as Archaea take over below this level, comprising of up to 87 percent of the deep sea biosphere. Contrary to popular belief, despite the extreme conditions, there exists a thriving ecosystem in the deep sea floor, with an estimated 90 million tons of biomass. The researchers believe that roughly 200 million cubic kilometers of mud just below the sea floor is inhabited by microorganisms.
In order to reach this conclusion, the scientists researched various samples of silt collected from hundreds of meters below the Atlantic and Pacific sea floor. The samples came from the research expeditions by the Integrated Ocean Drilling Program. Following this groundbreaking discovery, the researchers, Drs. Inagaki and Morono, have clearly outlined their vision for the future. With the strong presence of Archaea in the deep ecosystem, they have stated that they "intend to study their lifestyle and metabolism, strategy for long-term survival, and ecological roles."
They will use CHIKYU, the world's only riser-equipped research vessel and drilling platform. By presenting and discussing their findings, it is hoped that scientists will be able to gain a more complete, reliable and accurate picture of the deep sea floor.
These microbes are literally dead by our normal standards, barely using any energy at all. Unlike bacteria, which reproduce rapidly, Archaea double themselves less than once a century.
Scientists believe that if there are any life on the other planets in our solar system, it will be like these Archaea, living at an extremely slow pace of life due to the similar conditions. Hypothetically, similar organisms may be living in the vents beneath the ice of Europa, or in the frozen water of Mars, so developing an understanding the Archaea is vital. Additionally, these microbes are likely to survive major Earth impacts by asteroids or a nuclear fallout, meaning that the this deep sea region is a likely refuge during extinction events.
Story Of The Sea
How does a drug marketed by a pharmaceutical giant go from superstar to scapegoat in a matter of mere months? That's what doctors who use the injectable drug Trasylol-Aprotinin are asking themselves after recent revelations that the drug, which is used to stop bleeding in 60 percent of heart surgery patients, causes side effects such as kidney failure, heart attack, encephalopathy, stroke and even death.
The drug, which is manufactured by Bayer AG and was approved in the United States in 1993, had been questioned in a January 2006 report by the New England Journal of Medicine, which found that Trasylol upped the risk of kidney failure after heart surgery by 259 percent and linked the drug with renal failure and future heart attacks.
Singing Its Praises
Ironically, the drug had been mentioned in The Washington Post in early January 2006 as an example of a drug so safe that it no longer required clinical study. The article stated that Trasylol dropped the risk of blood transfusions in bypass patients by one-third and that after only 12 of 64 clinical studies, its advantages were clear. Amazingly, the article stated that if researchers had used the positive information from previous studies, they would not have needed to run their own clinical trials.
Tides Turn for Trasylol
The above article ran on January 2, 2006. However, in only 24 days, the tide had turned for Trasylol after the New England Journal of Medicine published its study of over 1,000 heart patients who received injections of Trasylol-Aprotinin. Bayer responded by insisting that the study was inherently flawed, but it came to the attention of the Food and Drug Administration (FDA), who warned doctors and patients of the drug's adverse side effects, which include increased risk of heart attack, stroke, and even the deadly brain disease encephalopathy.
Though Bayer has tried to discredit this study and market the drug for other procedures (including hip replacement surgery), lawsuits have begun to flow in as more and more patients have been found who have experienced detrimental side effects from the use of Trasylol-Aprotinin in their heart surgeries.
Have You Suffered Side Effects?
If you or a loved one have suffered side effects, such as stroke, heart attack, encephalopathy or even death, after the use of Trasylol-Aprotinin in a surgical heart procedure, you may be eligible for compensation and damages for your lost wages, medical care, future medical care, loss of consort, and/or emotional and physical pain and suffering. Contact an experienced pharmaceutical attorney who can help you evaluate your claim and attain the compensation you deserve.
Both Sara Jones & are contributors for EditorialToday. The above articles have been edited for relevancy and timeliness. All write-ups, reviews, tips and guides published by EditorialToday.com and its partners or affiliates are for informational purposes only. They should not be used for any legal or any other type of advice. We do not endorse any author, contributor, writer or article posted by our team.
Sara Jones has sinced written about articles on various topics from Web Development, Children and Vitamin and Mineral Supplement. Sara Jones was a fine student but science was a source of frustration she didn't want her kids to suffer. She met and realized their gras. Sara Jones's top article generates over 27100 views. to your Favourites.
has sinced written about articles on various topics from . . 's top article . to your Favourites.
Approaches To Language Learning - Edit if necessary to eliminate excessive pauses or add definite articles.- Finally, convert to MP3 or WMA. Now you can use your iPod or portable media player for something besides music.